Pronostiqueurs
*2011*mutations of mortality: TP53 again: "WE know that TP53 problems are about the worst you can have with CLL, but we also know that 17p deletion is very rare in newly diagnosed pat..."
*2008*mutations of mortality: TP53: is it such a big deal?: "Everyone knows that p53 abnormalities bode ill for patients with CLL. Generally such leukemias are resistant to fludarabine, cyclophosphamid..."
*2009*mutations of mortality: P53 explored: "Of all the malign features of CLL, damage to the p53 pathway is the most serious. Most drugs used in CLL work by invoking the p53 pathway to..."
*2007*mutations of mortality: Hope for p53 mutants: "The worst cases of CLL are those with reduced or absent p53 function. There are two reasons for this. p53 is known as ‘the guardian of the g..."
*2011*mutations of mortality: ZAP-70 again: "As readers know I am less than enthusiastic about ZAP-70 as a surrogate for IGHV mutations. I came across this conversation on the web which..."
*2010*mutations of mortality: ZAP-70 changes: "In order to make this paper available to all. ZAP-70 levels do change in CLL but not very often.Terry J Hamblin Abstract Evidence is accum..."
*2007*mutations of mortality: ZAP-70 again.: "One of the most pressing topics to come up in Canada was the usefulness or otherwise of ZAP-70 as a prognostic factor. In fact John Byrd sai..."
*2007*mutations of mortality: ZAP-70: "ZAP-70 is a molecule used to transmit a signal from the T-cell receptor to downstream pathways. Most B cells lack ZAP-70 and instead use a r..."
*2010*mutations of mortality: More on 13q14: "I have been promising to write something more about the 13q14 deletion in CLL. I have already visited this subject several times and claim s..."
*2010*mutations of mortality: A del 13q anomaly explained: "After Carlo Croce stressed the importance of the miR-15 and 16 genes in del 13q14 CLL we had a bit of problem because the smallest minimally..."
*2010*mutations of mortality: Del 13q14 - the Bournemouth background: "I feel a sort of ownership for del 13q14, since it was on some of my patients that the first cases in both CLL and myeloma that it was disco..."
*2011*mutations of mortality: Alkylating agents for del 11q: "I am sure you will recognise the Dohner et al hierarchical model for FISH results in CLL. This graph has been published hundreds of times. ..."
*2007*mutations of mortality: Del 11q23: "I am responding to one of my correspondents up front because not everybody reads the 'comments' on this blog. 'Anonymous' has misinterpreted..."
*2008*mutations of mortality: CD38 polymorphisms: "Why are we all so different? The plain answer is genetic polymorphisms. Perhaps the best known example is sickle cell anemia. Most people ha..."
*2007*mutations of mortality: Up to date on CD38: "Readers may have noticed that I have not yet delivered my promised summary of the IWCLL meeting. This is because I have been working on one ..."
*2005*mutations of mortality: CLLs discordant for VH mutations and CD38 have an ...: "CLLs discordant for VH mutations and CD38 have an intermediate prognosis "
*2005*mutations of mortality: This was the original graph from the Chiorazzi pap...: "This was the original graph from the Chiorazzi paper showing that CD38 was a useful prognostic factor "
*2005*mutations of mortality: CD38: "Somebody recently asked on the ACOR List CD38 and VH genes interalate. Let's first think about CD38. It has been mentioned in well over 1000..."
*2008*mutations of mortality: SNIPs: "The prognostic factors of CLL are well established and include clinical stage, IgVH mutational status, CD38 expression, ZAP-70 expression (w..."
*2008*mutations of mortality: CD20 and trisomy 12: "In advice that I have been giving over the past 5 years I have been stressing that CD20 is brighter in patients who have trisomy 12. Indeed ..."
*2006*mutations of mortality: Soluble CD23: "CD23 is the low affinity receptor for IgE. When it appears on eosinophils and macrophages it helps these cells to kill and eat structures th..."
*2008*mutations of mortality: FISH and mutations: "I have recently been asked whether del 11q is also influenced by the mutational status of IgVH genes. As you can see by these two survival..."
*2006*mutations of mortality: Del 17p: "One of the most feared findings in CLL is a loss of the short arm of chromosome 17. It is usually found by FISH testing and the technical te..."
*2008*mutations of mortality: FCRL2; a new prognostic marker for CLL: "In a forthcoming issue of Blood there will be an article on FCRL2, a new prognsotic factor for CLL. The discovery that patients with chroni..."
*2005*mutations of mortality: One picture is worth a thousamd words. This surviv...: "One picture is worth a thousamd words. This survival curve shows the difference between having mutated and unmutated VH genes. "
*2005*mutations of mortality: VH mutations: "I well remember a meeting in Italy when VH gene mutations were the hot topic. I was in the camp that believed that CLL was frozen in time as..."
*2007*mutations of mortality: Beta-2 microglobulin: "I am beginning to have a different view of beta-2 microglobulin as a prognostic factor in CLL. Hitherto, I have been suspicious of its value..."
*2005*mutations of mortality: Beta-2 microglobulin: "Beta-2 microglobulin is used by some centers as a prognostic factor and is particularly favored by the MD Anderson Cancer Center in Houston...."
*2008*mutations of mortality: CLL; Assessment of prognosis: "In chronic lymphocytic leukaemia, a third of patients never need treatment and have long survival; in another third, an initial indolent pha..."
*2007*mutations of mortality: How many mutations are you allowed?: "Legend of figure. Figure 1. Comparison of survival in months of patients with CLL with different degrees of sequence homology for IgVH g..."
Libellés
LLC
(100)
LLC 11q-
(2)
LLC anticorp monoclonal
(4)
LLC avis sur les traitements
(2)
LLC consultation mon cas
(11)
LLC Définition
(2)
LLC Dr Terry Hamblin
(13)
LLC éléments analysés
(5)
LLC Essais Cliniques
(11)
LLC étude d'un point
(4)
LLC exemple de traitement
(1)
LLC Genetique
(2)
LLC groupe de patients
(1)
LLC immunodepression
(1)
LLC les bases
(1)
LLC Mes Analyses
(6)
LLC molecule
(16)
LLC Molecule Arzerra
(1)
LLC Molecule Cirmtuzumab
(1)
LLC Molecule Gaziva
(1)
LLC molecule Ibrutinib
(3)
LLC molecule idelalisib
(2)
LLC MonTraitement1
(9)
LLC revue du net
(1)
LLC statistique survie
(8)
LLC témoignage après chimio
(1)
LLC témoignage chimio
(4)
LLC TH But du traitement
(1)
LLC TH Conseils
(1)
LLC TH CT scan
(1)
LLC TH Etudes
(1)
LLC TH Greffe
(1)
LLC TH Immunodeficience
(2)
LLC TH Les Traitements
(1)
LLC TH MBR
(1)
LLC TH Molecules
(1)
LLC TH Pronostiqueurs
(1)
LLC Traitement
(10)
LLC video
(1)
Traitement
(1)
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire